OCEAN BIOMEDICAL, INC. Share-based Payment Arrangement, Expense
OCEAN BIOMEDICAL, INC. (OCEA) reported Share-based Payment Arrangement, Expense of $186.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-15
- OCEAN BIOMEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $186.00K, a 0.00% change year-over-year.
- OCEAN BIOMEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $186.00K, a 0.53% decline year-over-year.
- OCEAN BIOMEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $186.00K, a 0.00% change year-over-year.
- OCEAN BIOMEDICAL, INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $187.00K, a 0.54% increase year-over-year.
- OCEAN BIOMEDICAL, INC. share-based payment arrangement, expense for fiscal 2024 was $745.00K, a 38.17% decline from fiscal 2023.
- OCEAN BIOMEDICAL, INC. share-based payment arrangement, expense for fiscal 2023 was $1.21M, a 90.26% decline from fiscal 2022.
- OCEAN BIOMEDICAL, INC. share-based payment arrangement, expense for fiscal 2022 was $12.38M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $186.00K 10-Q · filed 2025-05-15 | $372.00K derived: sum of 2 quarters · filed 2025-05-15 | $558.00K derived: sum of 3 quarters · filed 2025-05-15 | $745.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $372.00K derived: sum of 2 quarters · filed 2025-04-08 | $559.00K derived: sum of 3 quarters · filed 2025-04-08 | $745.00K 10-K · filed 2025-04-08 |
| 2024-09-30 | $186.00K 10-Q · filed 2025-01-13 | $373.00K derived: sum of 2 quarters · filed 2025-01-13 | $559.00K 10-Q · filed 2025-01-13 | $746.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $187.00K 10-Q · filed 2024-12-23 | $373.00K 10-Q · filed 2024-12-23 | $560.00K derived: sum of 3 quarters · filed 2025-05-15 | $746.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $186.00K 10-Q · filed 2025-05-15 | $373.00K derived: sum of 2 quarters · filed 2025-05-15 | $559.00K derived: sum of 3 quarters · filed 2025-05-15 | $745.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $373.00K derived: sum of 2 quarters · filed 2025-04-08 | $559.00K derived: sum of 3 quarters · filed 2025-04-08 | $1.21M 10-K · filed 2025-04-08 |
| 2023-09-30 | $186.00K 10-Q · filed 2025-01-13 | $372.00K derived: sum of 2 quarters · filed 2025-01-13 | $1.02M 10-Q · filed 2025-01-13 | $1.02M derived: sum of 4 quarters · filed 2025-01-13 |
| 2023-06-30 | $186.00K 10-Q · filed 2024-12-23 | $832.00K 10-Q · filed 2024-12-23 | $832.00K derived: sum of 3 quarters · filed 2024-12-23 | $3.77M derived: sum of 4 quarters · filed 2024-12-23 |
| 2023-03-31 | $646.00K 10-Q · filed 2024-12-23 | $646.00K derived: sum of 2 quarters · filed 2024-12-23 | $3.58M derived: sum of 3 quarters · filed 2024-12-23 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-25 | $2.93M derived: sum of 2 quarters · filed 2024-11-25 | $12.38M 10-K · filed 2024-11-25 | |
| 2022-09-30 | $2.93M 10-Q · filed 2024-04-15 | $12.38M 10-Q · filed 2024-04-15 |